$MBRX News Article - European Medicines Agency (EMA) Grants

New Post Public Reply Private Reply Replies (0) Message Board
whytestocks
188
$MBRX News Article - European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/euro...32468.html

Moleculin Biotech, Inc. (MBRX) Stock Research Links

MBRX Board Company Profile Buy Rating Time & Sales News Filings Financials
My Twitter: WhyteStocks